Oct 16, 2019 7:00 am EDT Castle Biosciences Announces Presentation of Prospective, Multicenter Study Demonstrating Significant Impact of DecisionDx-UM on Treatment Plan Recommendations for Patients with Uveal Melanoma
Oct 7, 2019 7:00 am EDT Newly Published Systematic Review Confirms Strength of Evidence and Outlines Appropriate Use Criteria for Integration of DecisionDx-Melanoma in Management of Patients with Cutaneous Melanoma
Sep 3, 2019 7:56 pm EDT Castle Biosciences Announces Time Change for Presentation at the Baird 2019 Global Healthcare Conference
Aug 27, 2019 7:00 am EDT Castle Biosciences to Present at the Baird 2019 Global Healthcare Conference
Aug 22, 2019 7:00 am EDT Castle Biosciences to Release Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, September 3, 2019
Jul 29, 2019 5:42 pm EDT Castle Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
